{"id":"NCT02692235","sponsor":"Gdansk University of Physical Education and Sport","briefTitle":"Carnitine Supplementation and Skeletal Muscle Function","officialTitle":"Carnitine Supplementation and Skeletal Muscle Function in Aging","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2017-03","completion":"2017-07","firstPosted":"2016-02-26","resultsPosted":"2019-05-09","lastUpdate":"2019-05-23"},"enrollment":28,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Sarcopenia"],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"carnitine","otherNames":[]},{"type":"DIETARY_SUPPLEMENT","name":"placebo","otherNames":[]}],"arms":[{"label":"carnitine","type":"EXPERIMENTAL"},{"label":"placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Research project objectives The primary aim of the current research project is to use carnitine supplementation as the anti-inflammatory intervention for exploring the relationship between inflammation and associated with aging reduction of skeletal muscle mass.\n\nHypothesis The carnitine supplementation modulates the blood cytokines concentration. Anti-inflammatory intervention delay the reduction of skeletal muscle mass associated with aging","primaryOutcome":{"measure":"Blood Inflammatory Marker","timeFrame":"baseline and after 24 weeks of supplementation period","effectByArm":[{"arm":"Carnitine","deltaMin":2.6,"sd":0.3},{"arm":"Placebo","deltaMin":1.8,"sd":0.3}],"pValues":[]},"eligibility":{"minAge":"65 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":1},"locations":{"siteCount":1,"countries":["Poland"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":["acid reflux","headache and dizziness"]}}